From December 5 to 6, 2020, the testing center of Changzhou Tongtai bio Pharmaceutical Technology Co., Ltd. passed the on-site review of CNAs.
one point one
Work report
The review team dispatched by CNAs reviews the whole elements of the accreditation criteria and reviews all technical capabilities applied for approval in accordance with the requirements of the requirements for the passing of testing and calibration laboratory capacity (CNAS-CL01 standards for accreditation of testing and calibration laboratories) of iso/iec 17025:2017. During the review, the quality records such as internal audit record, management review record, supplier review record and contract review record were randomly checked; through field test, the testing ability of the tester, familiarity with standards and familiarity with the testing process were assessed, and technical records such as typical test report and original record were spot checked; and relevant relevant records were checked through on-site questioning The authorized signer of the field has been assessed.
two
Experts give comments
Through on-site review, the review team believes that: the organization structure of the company's testing center is clear, internal responsibilities are reasonably allocated, personnel capacity meets the requirements, equipment environment meets the needs, all activities are under control, meeting the approval requirements, and the review team agrees to recommend and approve to CNAs.
CNAs accreditation certificate
On March 4, 2021, China National Accreditation Committee for conformity assessment awarded CNAs accreditation qualification of Changzhou Tongtai Biological Pharmaceutical Technology Co., Ltd. testing center, allowing our company to use CNAs identification mark, ilac-mra/cnas identification and declaration approval status in accordance with the provisions of cnas-r01.
an>